Linear Diagnostics Seed
2 known investors
Linear Diagnostics develops near-patient (point-of-care) diagnostic technology using EXPAR that delivers results in under 15 minutes, initially focused on detecting sexually transmitted infections and other infectious diseases. Its rapid testing is aimed at STI clinics to enable immediate treatment and reduce onward transmission.
Investors · 2
Frequently asked questions
- What does Linear Diagnostics Seed do?
- Linear Diagnostics develops near-patient (point-of-care) diagnostic technology using EXPAR that delivers results in under 15 minutes, initially focused on detecting sexually transmitted infections and other infectious diseases. Its rapid testing is aimed at STI clinics to enable immediate treatment and reduce onward transmission.
- Who are Linear Diagnostics Seed's investors?
- Linear Diagnostics Seed's investors include Future Planet Capital, Midven Ltd..